メーカー別の市場細分化では、レポートは次の企業をカバーしています-
Hoffmann-La Roche Ltd
Siemens Healthineers
Abbott Laboratories
Beckman Coulter, Inc.
SQI Diagnostics
Quest Diagnostics
EUROIMMUN AG
AESKU.Diagnostics GmbH & Co. KG
INOVA Diagnostics, Inc.
Crescendo Bioscience, Inc.
bioMerieux SA
Bio-Rad Laboratories, Inc.
Hemagen Diagnostics, Inc.
Global Localized Autoimmune Disease Diagnostics Market Research Report 2021-2028, by Manufacturers, Regions, Types and Applications
1 Study Coverage
1.1 Localized Autoimmune Disease Diagnostics Product
1.2 Key Market Segments in This Study
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Localized Autoimmune Disease Diagnostics Market Size Growth Rate by Type
1.4.2 Multiple Sclerosis
1.4.3 Type 1 Diabetes
1.4.4 Hashimotos Thyroiditis
1.4.5 Idiopathic Thrombocytopenic Purpura
1.4.6 Others
1.5 Market by Application
1.5.1 Global Localized Autoimmune Disease Diagnostics Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Research Institute
1.5.5 Laboratories
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Localized Autoimmune Disease Diagnostics Production
2.1.1 Global Localized Autoimmune Disease Diagnostics Revenue 2015-2028
2.1.2 Global Localized Autoimmune Disease Diagnostics Production 2015-2028
2.1.3 Global Localized Autoimmune Disease Diagnostics Capacity 2015-2028
2.1.4 Global Localized Autoimmune Disease Diagnostics Marketing Pricing and Trends
2.2 Localized Autoimmune Disease Diagnostics Growth Rate (CAGR) 2021-2028
2.3 Analysis of Competitive Landscape
2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
2.3.2 Key Localized Autoimmune Disease Diagnostics Manufacturers
2.4 Market Drivers, Trends and Issues
2.5 Macroscopic Indicator
2.5.1 GDP for Major Regions
2.5.2 Price of Raw Materials in Dollars: Evolution
3 Market Size by Manufacturers
3.1 Localized Autoimmune Disease Diagnostics Production by Manufacturers
3.1.1 Localized Autoimmune Disease Diagnostics Production by Manufacturers
3.1.2 Localized Autoimmune Disease Diagnostics Production Market Share by Manufacturers
3.2 Localized Autoimmune Disease Diagnostics Revenue by Manufacturers
3.2.1 Localized Autoimmune Disease Diagnostics Revenue by Manufacturers (2015-2020)
3.2.2 Localized Autoimmune Disease Diagnostics Revenue Share by Manufacturers (2015-2020)
3.3 Localized Autoimmune Disease Diagnostics Price by Manufacturers
3.4 Mergers & Acquisitions, Expansion Plans
4 Localized Autoimmune Disease Diagnostics Production by Regions
4.1 Global Localized Autoimmune Disease Diagnostics Production by Regions
4.1.1 Global Localized Autoimmune Disease Diagnostics Production Market Share by Regions
4.1.2 Global Localized Autoimmune Disease Diagnostics Revenue Market Share by Regions
4.2 United States
4.2.1 United States Localized Autoimmune Disease Diagnostics Production
4.2.2 United States Localized Autoimmune Disease Diagnostics Revenue
4.2.3 Key Players in United States
4.2.4 United States Localized Autoimmune Disease Diagnostics Import & Export
4.3 Europe
4.3.1 Europe Localized Autoimmune Disease Diagnostics Production
4.3.2 Europe Localized Autoimmune Disease Diagnostics Revenue
4.3.3 Key Players in Europe
4.3.4 Europe Localized Autoimmune Disease Diagnostics Import & Export
4.4 China
4.4.1 China Localized Autoimmune Disease Diagnostics Production
4.4.2 China Localized Autoimmune Disease Diagnostics Revenue
4.4.3 Key Players in China
4.4.4 China Localized Autoimmune Disease Diagnostics Import & Export
4.5 Japan
4.5.1 Japan Localized Autoimmune Disease Diagnostics Production
4.5.2 Japan Localized Autoimmune Disease Diagnostics Revenue
4.5.3 Key Players in Japan
4.5.4 Japan Localized Autoimmune Disease Diagnostics Import & Export
4.6 Other Regions
4.6.1 South Korea
4.6.2 India
4.6.3 Southeast Asia
5 Localized Autoimmune Disease Diagnostics Consumption by Regions
5.1 Global Localized Autoimmune Disease Diagnostics Consumption by Regions
5.1.1 Global Localized Autoimmune Disease Diagnostics Consumption by Regions
5.1.2 Global Localized Autoimmune Disease Diagnostics Consumption Market Share by Regions
5.2 North America
5.2.1 North America Localized Autoimmune Disease Diagnostics Consumption by Application
5.2.2 North America Localized Autoimmune Disease Diagnostics Consumption by Countries
5.2.3 United States
5.2.4 Canada
5.2.5 Mexico
5.3 Europe
5.3.1 Europe Localized Autoimmune Disease Diagnostics Consumption by Application
5.3.2 Europe Localized Autoimmune Disease Diagnostics Consumption by Countries
5.3.3 Germany
5.3.4 France
5.3.5 UK
5.3.6 Italy
5.3.7 Russia
5.4 Asia Pacific
5.4.1 Asia Pacific Localized Autoimmune Disease Diagnostics Consumption by Application
5.4.2 Asia Pacific Localized Autoimmune Disease Diagnostics Consumption by Countries
5.4.3 China
5.4.4 Japan
5.4.5 South Korea
5.4.6 India
5.4.7 Australia
5.4.8 Indonesia
5.4.9 Thailand
5.4.10 Malaysia
5.4.11 Philippines
5.4.12 Vietnam
5.5 Central & South America
5.5.1 Central & South America Localized Autoimmune Disease Diagnostics Consumption by Application
5.5.2 Central & South America Localized Autoimmune Disease Diagnostics Consumption by Countries
5.5.3 Brazil
5.6 Middle East and Africa
5.6.1 Middle East and Africa Localized Autoimmune Disease Diagnostics Consumption by Application
5.6.2 Middle East and Africa Localized Autoimmune Disease Diagnostics Consumption by Countries
5.6.3 Turkey
5.6.4 GCC Countries
5.6.5 Egypt
5.6.6 South Africa
6 Market Size by Type
6.1 Global Localized Autoimmune Disease Diagnostics Breakdown Dada by Type
6.2 Global Localized Autoimmune Disease Diagnostics Revenue by Type
6.3 Localized Autoimmune Disease Diagnostics Price by Type
7 Market Size by Application
7.1 Overview
7.2 Global Localized Autoimmune Disease Diagnostics Breakdown Dada by Application
7.2.1 Global Localized Autoimmune Disease Diagnostics Consumption by Application
7.2.2 Global Localized Autoimmune Disease Diagnostics Consumption Market Share by Application (2015-2020)
8 Manufacturers Profiles
8.1 Hoffmann-La Roche Ltd
8.1.1 Hoffmann-La Roche Ltd Company Details
8.1.2 Company Description
8.1.3 Capacity, Production and Value of Localized Autoimmune Disease Diagnostics
8.1.4 Localized Autoimmune Disease Diagnostics Product Description
8.1.5 SWOT Analysis
8.2 Siemens Healthineers
8.2.1 Siemens Healthineers Company Details
8.2.2 Company Description
8.2.3 Capacity, Production and Value of Localized Autoimmune Disease Diagnostics
8.2.4 Localized Autoimmune Disease Diagnostics Product Description
8.2.5 SWOT Analysis
8.3 Abbott Laboratories
8.3.1 Abbott Laboratories Company Details
8.3.2 Company Description
8.3.3 Capacity, Production and Value of Localized Autoimmune Disease Diagnostics
8.3.4 Localized Autoimmune Disease Diagnostics Product Description
8.3.5 SWOT Analysis
8.4 Beckman Coulter, Inc.
8.4.1 Beckman Coulter, Inc. Company Details
8.4.2 Company Description
8.4.3 Capacity, Production and Value of Localized Autoimmune Disease Diagnostics
8.4.4 Localized Autoimmune Disease Diagnostics Product Description
8.4.5 SWOT Analysis
8.5 SQI Diagnostics
8.5.1 SQI Diagnostics Company Details
8.5.2 Company Description
8.5.3 Capacity, Production and Value of Localized Autoimmune Disease Diagnostics
8.5.4 Localized Autoimmune Disease Diagnostics Product Description
8.5.5 SWOT Analysis
8.6 Quest Diagnostics
8.6.1 Quest Diagnostics Company Details
8.6.2 Company Description
8.6.3 Capacity, Production and Value of Localized Autoimmune Disease Diagnostics
8.6.4 Localized Autoimmune Disease Diagnostics Product Description
8.6.5 SWOT Analysis
8.7 EUROIMMUN AG
8.7.1 EUROIMMUN AG Company Details
8.7.2 Company Description
8.7.3 Capacity, Production and Value of Localized Autoimmune Disease Diagnostics
8.7.4 Localized Autoimmune Disease Diagnostics Product Description
8.7.5 SWOT Analysis
8.8 AESKU.Diagnostics GmbH & Co. KG
8.8.1 AESKU.Diagnostics GmbH & Co. KG Company Details
8.8.2 Company Description
8.8.3 Capacity, Production and Value of Localized Autoimmune Disease Diagnostics
8.8.4 Localized Autoimmune Disease Diagnostics Product Description
8.8.5 SWOT Analysis
8.9 INOVA Diagnostics, Inc.
8.9.1 INOVA Diagnostics, Inc. Company Details
8.9.2 Company Description
8.9.3 Capacity, Production and Value of Localized Autoimmune Disease Diagnostics
8.9.4 Localized Autoimmune Disease Diagnostics Product Description
8.9.5 SWOT Analysis
8.10 Crescendo Bioscience, Inc.
8.10.1 Crescendo Bioscience, Inc. Company Details
8.10.2 Company Description
8.10.3 Capacity, Production and Value of Localized Autoimmune Disease Diagnostics
8.10.4 Localized Autoimmune Disease Diagnostics Product Description
8.10.5 SWOT Analysis
8.11 bioMerieux SA
8.12 Bio-Rad Laboratories, Inc.
8.13 Hemagen Diagnostics, Inc.
9 Production Forecasts
9.1 Localized Autoimmune Disease Diagnostics Production and Revenue Forecast
9.1.1 Global Localized Autoimmune Disease Diagnostics Production Forecast 2021-2028
9.1.2 Global Localized Autoimmune Disease Diagnostics Revenue Forecast 2021-2028
9.2 Localized Autoimmune Disease Diagnostics Production and Revenue Forecast by Regions
9.2.1 Global Localized Autoimmune Disease Diagnostics Revenue Forecast by Regions
9.2.2 Global Localized Autoimmune Disease Diagnostics Production Forecast by Regions
9.3 Localized Autoimmune Disease Diagnostics Key Producers Forecast
9.3.1 United States
9.3.2 Europe
9.3.3 China
9.3.4 Japan
9.4 Forecast by Type
9.4.1 Global Localized Autoimmune Disease Diagnostics Production Forecast by Type
9.4.2 Global Localized Autoimmune Disease Diagnostics Revenue Forecast by Type
10 Consumption Forecast
10.1 Consumption Forecast by Application
10.2 Localized Autoimmune Disease Diagnostics Consumption Forecast by Regions
10.3 North America Market Consumption Forecast
10.3.1 North America Localized Autoimmune Disease Diagnostics Consumption Forecast by Countries 2021-2028
10.3.2 United States
10.3.3 Canada
10.3.4 Mexico
10.4 Europe Market Consumption Forecast
10.4.1 Europe Localized Autoimmune Disease Diagnostics Consumption Forecast by Countries 2021-2028
10.4.2 Germany
10.4.3 France
10.4.4 UK
10.4.5 Italy
10.4.6 Russia
10.5 Asia Pacific Market Consumption Forecast
10.5.1 Asia Pacific Localized Autoimmune Disease Diagnostics Consumption Forecast by Countries 2021-2028
10.5.2 China
10.5.3 Japan
10.5.4 Korea
10.5.5 India
10.5.6 Australia
10.5.7 Indonesia
10.5.8 Thailand
10.5.9 Malaysia
10.5.10 Philippines
10.5.11 Vietnam
10.6 Central & South America Market Consumption Forecast
10.6.1 Central & South America Localized Autoimmune Disease Diagnostics Consumption Forecast by Country 2021-2028
10.6.2 Brazil
10.7 Middle East and Africa Market Consumption Forecast
10.7.1 Middle East and Africa Localized Autoimmune Disease Diagnostics Consumption Forecast by Countries 2021-2028
10.7.2 Middle East and Africa
10.7.3 Turkey
10.7.4 GCC Countries
10.7.5 Egypt
10.7.6 South Africa
11 Upstream, Industry Chain and Downstream Customers Analysis
11.1 Analysis of Localized Autoimmune Disease Diagnostics Upstream Market
11.1.1 Localized Autoimmune Disease Diagnostics Key Raw Material
11.1.2 Typical Suppliers of Key Localized Autoimmune Disease Diagnostics Raw Material
11.1.3 Localized Autoimmune Disease Diagnostics Raw Material Market Concentration Rate
11.2 Localized Autoimmune Disease Diagnostics Industry Chain Analysis
11.3 Marketing & Distribution
11.4 Localized Autoimmune Disease Diagnostics Distributors
11.5 Localized Autoimmune Disease Diagnostics Customers
12 Opportunities & Challenges, Threat and Affecting Factors
12.1 Market Opportunities
12.2 Market Challenges
12.3 Porters Five Forces Analysis
13 Key Findings
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer